PAH treatment Opsynvi endorsed by patients, clinicians
Patients and clinicians endorsed Opsynvi as a single-tablet combination therapy for PAH in interviews conducted during a clinical trial.| Pulmonary Hypertension News
Patients and clinicians endorsed Opsynvi as a single-tablet combination therapy for PAH in interviews conducted during a clinical trial.| Pulmonary Hypertension News
While PH Awareness Month is a great opportunity to connect and educate, rare disease advocacy is columnist Jen Cueva's passion all year.| Pulmonary Hypertension News
Exosomes released by mesenchymal stem cells may help reduce vascular remodeling and ease PH symptoms, a rat study showed.| Pulmonary Hypertension News
LungFit PH, Beyond Air's nitric oxide therapy device, has received the European CE mark approval for pulmonary hypertension in newborns.| Pulmonary Hypertension News
The immune protein STAT6 may be a driver of pulmonary hypertension in people with obstructive sleep apnea, a study in mice suggests.| Pulmonary Hypertension News
Platelets tend to cluster in lung blood vessels in people with decompensated pulmonary hypertension, increasing their risk of bleeding, a study says.| Pulmonary Hypertension News
Category archive page for Columns.| Pulmonary Hypertension News
